Leadership Overview
ICON has 4 executives leading key functions including drug development, commercialization, and people operations.
Driven by a commitment to advancing health, ICON provides comprehensive drug and device development services to global pharmaceutical, biotechnology, and government organizations, impacting public health worldwide.
Driven by a commitment to advancing health, ICON provides comprehensive drug and device development services to global pharmaceutical, biotechnology, and government organizations, impacting public health worldwide.
Leadership Roles at ICON
Deepali Suri - President, ICON Biotech
Deepali Suri, the President, ICON Biotech at ICON, directs the strategic expansion and operational execution of ICON's biotechnology division. This leadership role involves overseeing the development and commercialization of innovative biopharmaceutical products, ensuring alignment with the company's core mission of advancing drug and device development services. Suri's oversight extends to managing complex research and development pipelines, fostering collaborations with biotechnology firms, and driving market penetration for novel therapies. By optimizing resource allocation and championing scientific advancement, Deepali Suri ensures ICON Biotech remains at the forefront of the industry, delivering critical solutions to pharmaceutical, biotechnology, and government organizations. The focus remains on accelerating the journey from discovery to market, thereby enhancing global public health outcomes through cutting-edge biotechnological solutions.
Thomas Marsland - President
Thomas Marsland, the President at ICON, drives the overarching strategic direction and operational efficiency across the organization. This executive position involves guiding ICON's comprehensive drug and device development and commercialization services, ensuring seamless integration between various business units. Marsland's responsibilities encompass fostering innovation, optimizing business processes, and expanding market reach for pharmaceutical, biotechnology, medical device, and government clients. By cultivating strong relationships with key stakeholders and championing a culture of excellence, Thomas Marsland ensures ICON consistently delivers high-value solutions that accelerate the development of life-changing therapies. The strategic imperative is to enhance ICON's position as a global leader, supporting public health initiatives through robust R&D and commercialization expertise.
Connie Inguanti - President, Symphony Health
Connie Inguanti, the President, Symphony Health at ICON, spearheads the strategic vision and operational management of ICON's Symphony Health division. This critical role focuses on leveraging data analytics and technology to provide advanced commercialization services to the pharmaceutical and biotechnology sectors. Inguanti directs the development and implementation of data-driven strategies that enhance market access, optimize product launches, and support evidence-based decision-making for clients. By ensuring the integrity and impact of Symphony Health's offerings, Connie Inguanti contributes significantly to ICON's mission of accelerating drug and device development. The leadership ensures that clients receive unparalleled insights and support, driving commercial success and ultimately benefiting public health through more effective product delivery.
Marian Colon-Nieves - Manager, Clinical Operations & Chief People Officer
Marian Colon-Nieves, the Manager, Clinical Operations & Chief People Officer at ICON, orchestrates the critical intersection of clinical operations and human capital management. This dual-focused leadership role ensures the efficient execution of clinical trials while simultaneously cultivating a high-performing and engaged workforce. Colon-Nieves directs the strategic development and implementation of people-centric initiatives that support ICON's mission of providing drug and device development services. This includes overseeing talent acquisition, employee development, and fostering a culture that drives innovation and operational excellence within clinical operations. By aligning human resources strategies with the demands of complex R&D projects, Marian Colon-Nieves ensures ICON's teams are equipped to meet the evolving needs of pharmaceutical, biotechnology, and government organizations, thereby advancing global health outcomes.
Explore Leadership Teams in Business Services
Founded in 1958 and headquartered in McLean, Virginia, The MITRE Corporation is a not-for-profit company providing engineering and technical guidance for the federal government.
Company Leadership
KK
DA
Founded in 1930, The Woods Hole Oceanographic Institution is a non-profit organization that supports marine research, engineering, and higher education. Woods Hole Oceanographic Institution is headquartered in Woods Hole, Massachusetts.
Company Leadership FS
KG
SH
KL
ECRI is an independent, nonprofit organization dedicated to advancing the safety, quality, and cost-effectiveness of healthcare across all settings. With a strong focus on patient safety, evidence-based practices, and technology decision support, ECRI is widely recognized and trusted by healthcare leaders and government agencies around the world. For over fifty years, ECRI has earned its reputation through integrity, rigorous research, and a steadfast commitment to independence, supported by strict conflict-of-interest policies. It remains the only organization globally to perform independent evaluations of medical devices, with testing laboratories located in both North America and the Asia Pacific region. ECRI is designated as an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality and is a federally certified Patient Safety Organization by the U.S. Department of Health and Human Services. In 2020, the Institute for Safe Medication Practices (ISMP) officially became an affiliate of ECRI.
Company Leadership DM
JN
DK
Sime Darby Industrial Australasia (SDIA) is a leader in the heavy equipment industry in our region. As part of the worlds largest Cat dealer groups, and with an operational footprint that covers Australia, New Zealand, Papua New Guinea, the Solomon Islands, and New Caledonia, SDIA offers industrial solutions that cater to the needs of its customers across various industries. SDIAs core businesses are in the sale and rental of heavy equipment and power systems, providing after-sales product support, and leveraging technology to develop innovative productivity solutions for customers in the resources, construction, power generation, forestry, marine, agriculture, material handling and oil & gas sectors. The group is continuing to grow and strengthen its presence in the market with a number of strategic, value-enhancing acquisitions, providing a base for expansion across the industrial sector in the wider Australasian region.
Company Leadership EA
MS
JC
GB
Frequently Asked Questions Regarding ICON Top Executives and Leadership Team
Unlock more people and company data
